Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSynergia Energy Regulatory News (SYN)

Share Price Information for Synergia Energy (SYN)

Share Price is delayed by 15 minutes
Get Live Data
0.0105    0.00 (0.00%)
Bid:
0.009
Ask:
0.012
Spread: 0.003 (33.333%)
Market Cap: £1.64m
SYN Live PriceLast checked at - London Stock Exchange

Intraday Synergia Energy Share Chart

Cambay Work Program Update

14 Oct 2024 07:00

RNS Number : 9365H
Synergia Energy Ltd
14 October 2024
 

RNS Announcement

 

14 October 2024

 

AIM: SYN

Cambay Work Program Update

 

Synergia Energy Ltd ("Synergia" or the "Company") provides the following update regarding the Company's Cambay PSC joint venture and its carbon capture and storage ("CCS") projects in the UK and India.

 

Cambay PSC

During the recent Technical Committee Meeting held by Synergia's JV partner, Selan Exploration Technology Limited ("Selan"), the planned work program associated with the Company's Cambay Field Production Sharing Contract ("Cambay PSC") in Gujarat State, India, and the sequence of workover operations for the candidate wells was finalised, subject to further individual well analysis:

Well Number Completion Operation

C-70 Perforate MBS formation

C-63 Wellbore cleanout; re-perforate; install artificial lift pump

C-64 Install artificial lift pump

C-73 Wellbore cleanout; install artificial lift pump

C-20 Install artificial lift pump

C-74 Wellbore cleanout; install artificial lift pump

C-77H Well data acquisition; finalize future workover program

Selan plan to conduct workover operations on a minimum 3 wells and potentially up to 6 wells on the Cambay PSC.

The workover sequence, starting with C-70, will commence after the wells have been subjected to individual pressure gradient surveys during October / November 2024. All the contracts required for the workover operations are progressing as per the timeline. The Company believes the workover program will result in material incremental production and cashflow from the Cambay PSC and a better understanding of well behaviour ahead of the drilling of three new wells which is currently planned to commence Q2 2025. Synergia will be carried by Selan through the agreed US$20 million work program.

 

Medway Hub Camelot CCS project

Synergia is the nominated operator of UK carbon storage license CS019 Camelot which is now a 50:50 joint venture with Harbour Energy. Synergia and its joint venture partner have been assiduously working through the NSTA work program which is currently in the site characterisation phase. Following the re-processing of the 3D seismic data set, the seismic interpretation is being finalised but initial results show a marked uplift in seismic data clarity and definition. In parallel, a number of other work streams are currently underway including geochemical and geomechanical studies, legacy well integrity analyses, petrophysical analysis and static and dynamic reservoir modelling.

The Company is encouraged by the recent announcement of the £22 billion investment plan to support CCS projects on Teesside and Merseyside by the UK Government. However, the Company's Medway Hub Camelot CCS project is being planned as a merchant scheme and is not predicated by future UK Government funding.

Cambay CCS Scheme

During July 2024, Synergia discussed its Cambay-based CCS scheme with the Directorate General of Hydrocarbons ("DGH") principals resulting in an agreement to develop and propose a proof of concept pilot project on the Cambay PSC. A recent meeting involving Synergia, DGH and Mumbai Institute of Technology personnel was held to progress the pilot project which the Company hopes will attract Government of India funding support.

 

 

 

This announcement contains inside information for the purposes of Article 7 of the Market Abuse Regulation (EU) 596/2014 as it forms part of UK domestic law by virtue of the European Union (Withdrawal) Act 2018 ("MAR") and is disclosed in accordance with the Company's obligations under Article 17 of MAR.

 

For and on behalf of Synergia Energy Limited

 

Roland Wessel

CEO

For further information, please contact:

 

Investor Enquires

Synergia Energy Ltd

Briana Stayt

Investor Relations

Email: 

bstayt@synergiaenergy.com

Tel: +61 8 9485 3200

Australia

AIM Joint Broker

Panmure Liberum Ltd

Broker

Mark Murphy / Rauf Munir / Freddie Wooding

Tel: +44 (0)20 7886 2500

UK

AIM Joint Broker

Novum Securities

Broker

Colin Rowbury

Email: 

crowbury@novumsecurities.com

Tel: +44 20 7399 9427

UK

AIM Nominated Adviser

Strand Hanson Limited

Nominated Adviser

Ritchie Balmer / Rory Murphy

Tel: +44 20 7409 3494

UK

Media Enquires (UK)

Vigo Consulting

Investor Relations

Patrick d'Ancona / Finlay Thomson

Email:

patrick.dancona@vigoconsulting.com

finlay.thomson@vigoconsulting.com

Tel:+ 44 20 7390 0230

UK

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
UPDZFLFFZBLFFBE
Date   Source Headline
3rd Sep 201911:55 amRNSForm 8.3 - Synnovia PLC
3rd Sep 201911:14 amGNWForm 8.3 - Synnovia plc
3rd Sep 20197:00 amRNSOffer by BPF1 Limited
2nd Sep 20193:33 pmRNSResult of AGM
8th Aug 20199:16 amRNSAnnual Financial Report
9th Jul 20197:00 amRNSFinal Results
3rd Jul 201910:51 amRNSNotice of Results
1st Jul 20192:48 pmRNSRefinancing of Banking Arrangements
1st Jul 20192:22 pmRNSDirector/PDMR Shareholding
25th Apr 20197:00 amRNSTrading Update and Restatement of Accounts
19th Feb 20197:00 amRNSTrading Statement
20th Dec 20184:37 pmRNSDirector/PDMR Shareholding
20th Dec 201811:35 amRNSResult of General Meeting and Change of Name
20th Dec 20187:00 amRNSDirector/PDMR Shareholding
14th Dec 20182:23 pmRNSDirector/PDMR Shareholding
14th Dec 201810:35 amRNSDirector/PDMR Shareholding
5th Dec 20186:27 pmRNSDirector/PDMR Shareholding
5th Dec 201810:16 amRNSHolding(s) in Company
5th Dec 201810:12 amRNSHolding(s) in Company
3rd Dec 20187:00 amRNSHalf-year Report
16th Nov 201811:01 amRNSNotice of Results
5th Oct 20188:00 amRNSTrading Statement
28th Aug 20188:36 amRNSHolding(s) in Company
30th Jul 20182:36 pmRNSResult of AGM
25th Jul 20181:54 pmRNSDirector/PDMR Shareholding
16th Jul 20188:13 amRNSDirector/PDMR Shareholding
9th Jul 20181:46 pmRNSAnnual Financial Report
2nd Jul 20187:00 amRNSFinal Results
22nd Jun 20187:00 amRNSNotice of Results
2nd May 20187:00 amRNSTrading Update
11th Apr 201811:02 amRNSUK Investor Show
16th Mar 20182:22 pmRNSDirector/PDMR Shareholding
1st Mar 20187:00 amRNSTrading Statement
6th Dec 20177:00 amRNSHalf-year Report
20th Nov 20179:38 amRNSNotice of Results
17th Nov 201710:54 amRNSHolding(s) in Company
5th Oct 20173:48 pmRNSDirector/PDMR Shareholding
3rd Oct 201712:43 pmRNSDirector/PDMR Dealing and Issue of Equity
2nd Oct 20177:00 amRNSTrading Update
1st Aug 20173:42 pmRNSResult of AGM
12th Jul 201711:32 amRNSHolding(s) in Company
11th Jul 20179:19 amRNSHolding(s) in Company
7th Jul 20174:41 pmRNSAnnual Financial Report
3rd Jul 20177:00 amRNSFinal Results
12th Jun 20177:00 amRNSNotice of Results
8th Jun 20175:06 pmRNSHolding(s) in Company
5th Jun 20179:32 amRNSHolding(s) in Company
1st Jun 20174:28 pmRNSApplication for Admission
26th May 20177:00 amRNSPlacing to raise £3.74 million
2nd May 20177:00 amRNSTrading Update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.